C. Saberian

发表

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

J. Wargo, P. Sharma, A. Lazar, 2022, Cancer cell.

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

J. McQuade, S. Faria, R. Amaria, 2021, Journal for ImmunoTherapy of Cancer.

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

M. Suarez‐Almazor, C. Yee, S. Tummala, 2019, Journal of Immunotherapy for Cancer.

Vorinostat combined with Busulfan, Fludarabine, and Clofarabine Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Leukemia: Long-term Study Outcomes.

P. Thall, D. Marin, E. Shpall, 2022, Transplantation and cellular therapy.

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation

M. Suarez‐Almazor, M. Konopleva, G. Garcia-Manero, 2021, Journal for ImmunoTherapy of Cancer.

Head‐and‐neck dermatitis: Diagnostic difficulties and management pearls

V. Shi, P. Lio, M. Maarouf, 2018, Pediatric dermatology.

Interleukin-6 Blockade Abrogates Immunotherapy Toxicity and Promotes Tumor Immunity

J. Wargo, P. Hwu, K. Wani, 2021, SSRN Electronic Journal.

Targeted therapy strategies for melanoma brain metastasis

P. Sperduto, C. Saberian, M. Davies, 2021, Neuro-oncology advances.

Re‐thinking therapeutic development for CNS metastatic disease

C. Saberian, M. Davies, 2021, Experimental dermatology.

Problematic smartphone use among Lebanese adults aged 18-65 years using MPPUS-10

Jumana Antoun, Marc Nahas, Sani Hlais, 2018, Comput. Hum. Behav..

Lag3: From Bench to Bedside.

M. Middleton, Insiya Jafferji, Reem Saleh, 2022, Cancer treatment and research.

Use of checkpoint inhibitors (CPI) in allogeneic stem cell transplant recipients: An institutional experience and a systemic review of the literature

M. Suarez‐Almazor, A. Diab, G. Alatrash, 2019, Annals of Oncology.

Rapidly Disseminated Kaposi’s Sarcoma Despite Initiation of Antiretroviral Therapy

C. Saberian, Breanna R. Campbell, 2023, Cureus.

Changes in outcomes and factors associated with survival in melanoma patients with brain metastases

Betty Y. S. Kim, S. McGovern, J. Huse, 2022, Neuro-oncology.

Interleukin-6 is potential target to de-couple checkpoint inhibitor-induced colitis from antitumor immunity.

K. Hess, A. Lazar, P. Hwu, 2019, Journal of Clinical Oncology.

658 Toxicities of single agent and combination immune checkpoint inhibitors in patients with pre-existing autoimmune diseases

M. Suarez‐Almazor, A. Pavlick, J. Weber, 2020, Journal for ImmunoTherapy of Cancer.